Carregant...
Fitxers
Tipus de document
ArticleVersió
Versió publicadaData de publicació
Llicència de publicació
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/220879
Combination of Apigenin and Melatonin with nanostructured lipid carriers as anti-inflammatory ocular treatment
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
Ocular inflammation is a complex pathology with limited treatment options. While traditional therapies have side effects, novel approaches, such as natural compounds like Apigenin (APG) and Melatonin (MEL) offer promising solutions. APG and MEL, in combination with nanostructured lipid carriers (NLC), may provide a synergistic effect in treating ocular inflammation, potentially improving patient outcomes and reducing adverse effects. NLC could provide chemical protection of these compounds, while offering a sustained release into the ocular surface. Optimized NLC exhibited suitable physicochemical parameters, physical stability, sustained release of APG and MEL, and were biocompatible in vitro with a corneal cell line, and in ovo by using hen's egg chorioallantoic membrane test. In vitro and in vivo studies confirmed the NLC' ability to attenuate inflammation by reducing interleukin-6 (IL-6), IL-8 and monocyte chemoattractant protein 1 (MCP-1) cytokine levels and by decreasing inflammation in a rabbit model. These findings suggest that the co-encapsulation of APG and MEL into NLC could represent a promising strategy for managing ocular inflammatory conditions.
Matèries
Matèries (anglès)
Citació
Citació
BONILLA VIDAL, Lorena, ESPINA GARCÍA, Marta, GARCÍA LÓPEZ, María luisa, BALDOMÀ LLAVINÉS, Laura, BADÍA PALACÍN, Josefa, GLISZCZYŃSKA, Anna, SOUTO, Eliana b., SÁNCHEZ-LÓPEZ, E. (elena). Combination of Apigenin and Melatonin with nanostructured lipid carriers as anti-inflammatory ocular treatment. _International Journal of Pharmaceutics_. 2025. Vol. 670. [consulta: 25 de gener de 2026]. ISSN: 0378-5173. [Disponible a: https://hdl.handle.net/2445/220879]